These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9165695)

  • 1. Therapy and prevention of gastric ulcer.
    Lamers CB; Biemond I; Masclee AA; Veenendaal RA
    Yale J Biol Med; 1996; 69(3):265-70. PubMed ID: 9165695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori infections.
    Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
    QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT; Cherian S; Singh P
    Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric ulcer and Helicobacter pylori infection].
    Tićak M; Prskalo M; Sabarić B; Dominis M; Skurla B; Dzebro S; Filipec T; Colić-Cvrlje V; Naumovski-Mihalić S; Papa B; Jelić D; Katicić M
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():43-7. PubMed ID: 12592816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peptic ulcer, Helicobacter pylori].
    Bauerfeind P; Wirth HP
    Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes of Helicobacter pylori obtained from gastric ulcer patients taking or not taking NSAIDs.
    Li L; Kelly LK; Ayub K; Graham DY; Go MF
    Am J Gastroenterol; 1999 Jun; 94(6):1502-7. PubMed ID: 10364014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C; Marbet UA
    Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What role today for Helicobacter pylori in peptic ulcer?].
    Cadiot G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.